Thymic malignancies treated with active scanning proton beam radiation and Monte Carlo planning: early clinical experience

References

• Tseng YD, Maes SM, Kicska G, et al. Comparative photon and proton dosimetry for patients with mediastinal lymphoma in the era of Monte Carlo treatment planning and variable relative biological effectiveness. Radiat Oncol. 2019;14(1):243.
   PubMed Web of Science ®Google Scholar
• Lim YJ, Kim E, Kim HJ, et al. Survival impact of adjuvant radiation therapy in Masaoka stage II to IV thymomas: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2016;94(5):1129–1136.
   PubMed Web of Science ®Google Scholar
• Omasa M, Date H, Sozu T, Japanese Association for Research on the Thymus, et al. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study. Cancer. 2015;121(7):1008–1016.
   PubMed Web of Science ®Google Scholar
• Moiseenko V, Craig T, Bezjak A, et al. Dose-volume analysis of lung complications in the radiation treatment of malignant thymoma: a retrospective review. Radiother Oncol. 2003;67(3):265–274.
   PubMed Web of Science ®Google Scholar
• Zhu HJ, Hoppe BS, Flampouri S, et al. Rationale and early outcomes for the management of thymoma with proton therapy. Transl Lung Cancer Res. 2018;7(2):106–113.
   PubMed Web of Science ®Google Scholar
• McGale P, Darby SC, Hall P, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol. 2011;100(2):167–175.
   PubMed Web of Science ®Google Scholar
• Maes D, Saini J, Zeng J, et al. Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer. Transl Lung Cancer Res. 2018;7(2):114–121.
   PubMed Web of Science ®Google Scholar
• Rimner A, Yao X, Huang J, et al. Postoperative radiation therapy is associated with longer overall survival in completely resected stage II and III thymoma-an analysis of the international thymic malignancies interest group retrospective database. J Thorac Oncol. 2016;11(10):1785–1792.
   PubMed Web of Science ®Google Scholar
• Figura N, Hoppe BS, Flampouri S, et al. Postoperative proton therapy in the management of stage III thymoma. J Thorac Oncol. 2013;8(5):e38–e40.
   PubMed Web of Science ®Google Scholar
• Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16(2):187–199.
   PubMed Web of Science ®Google Scholar
• Berman AT, Litzky L, Livolsi V, et al. Adjuvant radiotherapy for completely resected stage 2 thymoma. Cancer. 2011;117(15):3502–3508.
   PubMed Web of Science ®Google Scholar
• Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5(10 Suppl 4):S260–S5.
   PubMed Web of Science ®Google Scholar
• Willmann J, Rimner A. The expanding role of radiation therapy for thymic malignancies. J Thorac Dis. 2018;10(Suppl 21):S2555–S64.
   PubMed Web of Science ®Google Scholar
• Zhang Y. A Multi-institutional, randomized controlled trial of postoperative conformal radiotherapy for stage II-III B type thymoma. 2020. Jul [cited 2021 Jan 20]. Available from: https://clinicaltrials.gov/ct2/show/NCT02014805.
   Google Scholar
• Parikh RR, Rhome R, Hug E, et al. Adjuvant proton beam therapy in the management of thymoma: a dosimetric comparison and acute toxicities. Clin Lung Cancer. 2016;17(5):362–366.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen L, Zhang S, et al. Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer. Thorac Cancer. 2015;6(1):49–57.
   PubMed Web of Science ®Google Scholar
• Wu K. An open-label, multi-center, randomized phase III study of adjuvant radiotherapy for stage II/III thymoma after complete resection. 2019; [cited 2021 Jan 20]. Available from: https://clinicaltrials.gov/ct2/show/NCT02633553
   Google Scholar
• Correa CR, Litt HI, Hwang W-T, et al. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol. 2007;25(21):3031–3037.
   PubMed Web of Science ®Google Scholar
• Jackson MW, Palma DA, Camidge DR, et al. The impact of postoperative radiotherapy for thymoma and thymic carcinoma. J Thoracic Oncol. 2017;12(4):734–744.
   PubMed Web of Science ®Google Scholar
• Vogel J, Berman AT, Lin L, et al. Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: early response and toxicity assessment. Radiother Oncol. 2016;118(3):504–509.
   PubMed Web of Science ®Google Scholar
• Taylor PA, Kry SF, Followill DS. Pencil beam algorithms are unsuitable for proton dose calculations in lung. Int J Radiat Oncol Biol Phys. 2017;99(3):750–756.
   PubMed Web of Science ®Google Scholar
• Mercado CE, Hartsell WF, Simone CB, et al. Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries. Acta Oncol. 2019;58(7):1036–1040.
   PubMed Web of Science ®Google Scholar
• Saini J, Maes D, Egan A, et al. Dosimetric evaluation of a commercial proton spot scanning Monte-Carlo dose algorithm: comparisons against measurements and simulations. Phys Med Biol. 2017;62(19):7659–7681.
   PubMed Web of Science ®Google Scholar
• Gomez D, Komaki R. Technical advances of radiation therapy for thymic malignancies. J Thorac Oncol. 2010;5(10 Suppl 4):S336–S343.
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–998.
   PubMed Web of Science ®Google Scholar